Immune-related adverse events (irAEs) and survival in solid tumors treated with immune checkpoint inhibitors (ICIs): A systematic review and meta-analysis.

被引：0
作者：
Grizzi, Giulia
Petrelli, Fausto
Ghidini, Michele
Ghidini, Antonio
Ratti, Margherita
Panni, Stefano
Cabiddu, Mary
Ghilardi, Mara
Borgonovo, Karen
Parati, Maria Chiara
Barni, Sandro
Tomasello, Gianluca
Passalacqua, Rodolfo
Berruti, Alfredo
Brighenti, Matteo
机构：
[1] ASST Cremona, Oncol Dept, Oncol Unit, Cremona, Italy
[2] ASST Bergamo Ovest, Treviglio, Italy
[3] ASST Cremona, Oncol Unit, Cremona, Italy
[4] Osped Cremona, ASST Cremona, Cremona, Italy
[5] Univ Brescia, Spedali Civili Hosp, Med Oncol, Brescia, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14130
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14130
引用
收藏
页数：1
相关论文
共 50 条
[21]   Association of immune-related adverse events (irAEs) with clinical benefit in patients with metastatic urothelial carcinoma (mUC) treated with immune-checkpoint inhibitors (ICIs). [J].
Vitale, Nuzzo Pier ;
Pond, Gregory Russell ;
Abou Alaiwi, Sarah ;
Nassar, Amin ;
Flippot, Ronan ;
Choueiri, Toni K. ;
Harshman, Lauren Christine ;
Sonpavde, Guru .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[22]   Treatment-related adverse events of combination immune checkpoint inhibitors: Systematic review and meta-analysis. [J].
Park, Robin ;
da Silva, Laercio Lopes ;
Riano, Ivy ;
Cristancho, Cagney ;
Saeed, Anwaar .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[23]   Preexisting autoantibodies as predictor of immune-related adverse events for advanced solid tumors treated with immune checkpoint inhibitors [J].
Daban, Arthur ;
Gonnin, Cecile ;
Vano, Yann-Alexandre ;
Phan, Letuan ;
Lillo-Lelouet, Agnes ;
Le Beller, Christine ;
Pouchot, Jacques ;
Fabre, Elizabeth ;
Weiss, Laurence ;
Tartour, Eric ;
Oudard, Stephane ;
Durey, Marie-Agnes Dragon ;
Simonaggio, Audrey .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[24]   Neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: a single institution retrospective analysis [J].
Malani, Rachna ;
Haggiagi, Aya ;
Holder, Jenessa ;
Shames, Yelena ;
Briggs, Samuel ;
Callahan, Margaret ;
Santomasso, Bianca .
NEUROLOGY, 2018, 90
[25]   Patterns of immune-related adverse events (irAEs) in adolescent and young adult (AYA) patients with melanoma receiving immune checkpoint inhibitors (ICIs) [J].
He, Jiasen ;
John, Ida ;
Afridi, Faraz ;
Sun, Mianen ;
Wang, Yinghong ;
Roth, Michael ;
McQuade, Jennifer Leigh .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[26]   Real world outcomes of immune-related adverse events (irAEs) among patients receiving immune checkpoint inhibitors (ICIs) in hospital settings [J].
George, S. ;
Zheng, Y. ;
Kim, R. ;
Yu, T. ;
Dreyfus, J. ;
Gayle, J. A. ;
Wassel, C. ;
Phatak, H. .
ANNALS OF ONCOLOGY, 2019, 30 :522-522
[27]   Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors [J].
Teng, Yi-Shan ;
Yu, Sebastian .
CURRENT ONCOLOGY, 2023, 30 (07) :6805-6819
[28]   Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management [J].
Muntyanu, Anastasiya ;
Netchiporouk, Elena ;
Gerstein, William ;
Gniadecki, Robert ;
Litvinov, Ivan V. .
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2021, 25 (01) :59-76
[29]   Eosinophil count and immune-related adverse events (irAEs) as predictive biomarkers of survival in patients with NSCLC treated with ICIs [J].
Giommoni, Elisa ;
Pillozzi, Serena ;
Ottanelli, Carlotta ;
Cosso, Federica ;
Caliman, Enrico ;
Mazzoni, Francesca ;
Fancelli, Sara ;
Lavacchi, Daniele ;
Brugia, Marco ;
Pellegrini, Elisa ;
Vannini, Agnese ;
Napolitano, Brunella ;
Sanza, Roberta Fuccio ;
Shabani, Sonia ;
Zepponi, Francesca ;
Pasqui, Adriano ;
Zenoni, Andrea ;
Antonuzzo, Lorenzo .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[30]   Autoimmune panels as predictors of immune-related adverse events (irAEs) in patients (pts) treated with immune checkpoint inhibitors (ALERT) [J].
Genta, S. ;
Yee, N. ;
Keshavarzi, S. ;
Heirali, A. ;
Hansen, A. R. ;
Siu, L. L. ;
Saibil, S. ;
Stayner, L-A. ;
Yanekina, M. ;
Pimentel Muniz, T. ;
Vilbert, M. ;
Bedard, P. ;
Abdul Razak, A. R. ;
Coburn, B. ;
Chruscinski, A. ;
Spreafico, A. .
ANNALS OF ONCOLOGY, 2021, 32 :S844-S845
12345